Partner With Us NRI

Company details

6M Return -15.27%
1Y Return -41.30%
Mkt Cap.(Cr) 3,170.68
Volume 4,728
Div Yield 0.35%
OI Chg %
Volume 4,728

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 970.66 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 24,153.35 -39,474.21
LAST 3M 70,482.80 -53,901.04
LAST 6M 141,118.09 -188,404.80
LAST 12M 210,965.84 -182,647.76


  • About Company
  • Company Info
  • Listing Info
  • Advanced Enzyme Technologies Limited is a manufacturing enzymes sector company having a market capitalization of is 5,100.96 Crores as of 15-May-2021. The company was incorporated in 1945. The company has reported its consolidated quarterly revenue of Rs. 139.09 Cr. at the end of December 2020. The company is found listed on the Bombay Stock Exchange (BSE) with the code 540025 and also listed on National Stock Exchange (NSE) with the symbol ADVENZYMES. Advanced Enzymes is the largest Indian enzyme company engaged in the research and development dedicated to marketing eco-safe solutions to a wide variety of industries like Pharmaceuticals, Baking, Agriculture, Waste Management, Textile, Leather, Distilling, Grain Processing, Juice Processing, etc, developed from over 65 indigenous enzymes & probiotics. As of March 31, 2020, the Company has 6 (six) direct subsidiaries and 5 (five) step-down subsidiaries. Out of which 3 (three) are Indian subsidiaries and 8 (eight) are foreign subsidiaries make a strong presence across 45 countries worldwide. With exports across 6 continents, they provide customized and effective enzyme solutions coupled with the best in technical advice and superior service. 20 patents. The company has granted more than 20 patents, currently having more than 550 employees, more than 25 years of fragmentation experience. The current fragmentation capacity of AETL is 470 m³. To strength, its product, Company spending on R & D as a percentage of turnover is increasing from past 4 years( As per March 2020, R & D cost to total turnover is 4.95%) Advanced Enzyme Technologies Limited (AETL) is having is earning 43% revenue from India and 57% revenue internationally. ATL is having high TTM EPS growth with Low debt. For F.Y 19-20. Annual net profits and Book value per share also increasing for the past 2 years. ATL is a company having zero promoter pledges and Strong cash-generating ability from its core business. As on 31-March 20, AETL is a company having zero promoter pledge and Strong cash-generating ability from core business.

Read More

No Data Found

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
Book Closure Date (Month) :
BSE Group : A
ISIN : INE837H01020

ICICIdirect Advanced Enzyme Technologies Ltd FAQ

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 26, 2022 04:01 PM the closing price of Advanced Enzyme Technologies Ltd was ₹ 283.60.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 26, 2022 04:01 PM, the market cap of Advanced Enzyme Technologies Ltd stood at ₹ 3,170.68.
The latest PE ratio of Advanced Enzyme Technologies Ltd as of May 26, 2022 04:01 PM is 26.46
The latest PB ratio of Advanced Enzyme Technologies Ltd as of May 26, 2022 04:01 PM is 0.34
The 52-week high of Advanced Enzyme Technologies Ltd is ₹ 486.95 while the 52-week low is ₹ 260.10 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote